Stem cell biologist William Rust has been quietly working on a cure for diabetes for more than a decade. Later this year, ...

Tolerance Bio has launched with an oversubscribed $17.2 million seed round and a goal to develop therapies for ...

Protein production company Nuclera has raised a $75 million Series C to bring its manufacturing platform to market next ...

Dutch biotech investor Forbion has raised two new funds to put into biotech companies, just 18 months after its last major ...

Eli Lilly plans to invest £279 million ($364 million) in the UK as part of a new government partnership in which the ...

Novartis used one of its priority review vouchers (PRV) to speed the September approval of Kisqali in early breast cancer, ...

Private equity firms TPG and Blackstone are working on a potential deal to buy Brent Saunders-led eye care company Bausch + ...

More than a year ago, Endpoints News made the decision that we needed a dedicated reporter covering the use of artificial ...

Novo Nordisk filed suit against another semaglutide compounder on Friday, bringing its total number of cases to 50. Both Novo ...

GSK announced another batch of positive data from its respiratory program with the investigational drug depemokimab, this ...

The full results from Pfizer’s pivotal study of its Duchenne muscular dystrophy gene therapy show patients saw no significant ...

Novartis has terminated a mid-stage trial of an oral treatment candidate for idiopathic pulmonary fibrosis, the company ...